← back to search

Carlomaurizio Montecucco

University of Pavia · IT
Area of research
Rheumatology · Pathology and Forensic Medicine
Research interest
Research interests include Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Systemic Sclerosis and Related Diseases, and Vasculitis and related conditions.
h-index
72
citations
22,607
works
844
NIH funding
primary concept
Medicine
email

Recent publications

Hand function impairment in Systemic Sclerosis: determinants through investigations of clinical, radiographic and ultrasonographic features.
2026cited by 0position: contributordoi
Application of machine learning techniques to explore the occurrence of macrophage activation syndrome in Still’s disease: results from the GIRRCS AOSD Study Group and the AIDA Network Still’s Disease Registry
Frontiers in Immunology 2026cited by 0position: middledoi
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project.
2025cited by 16position: contributordoi
Managing the clinical heterogeneity of patients with Still's disease, from early diagnosis to timely treatment
Autoimmunity Reviews 2025cited by 3position: middledoi
High serum levels of CXCL13 predict lower response to csDMARDs in both ACPA-positive and ACPA-negative early rheumatoid arthritis.
2025cited by 2position: contributordoi
Pulmonary arterial hypertension in systemic lupus erythematosus: identification of risk factors and haemodynamics characteristics in a multicentre retrospective cohort
Lupus Science & Medicine 2025cited by 1position: middledoi
POS1301 EARLY COMBINATION WITH BELIMUMAB LEADS TO EARLIER RENAL RESPONSE AND LOWER CORTICOSTEROID USE IN LUPUS NEPHRITIS PATIENTS: DATA FROM A REAL-LIFE MULTICENTRIC STUDY
Annals of the Rheumatic Diseases 2025cited by 0position: middledoi
Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project
Arthritis & Rheumatology 2024cited by 25position: middledoi
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus
Autoimmunity Reviews 2024cited by 21position: middledoi
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study
RMD Open 2024cited by 19position: middledoi
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank
Clinical and Experimental Rheumatology 2024cited by 17position: middledoi
The Systemic Score May Identify Life‐Threatening Evolution in Still Disease: Data from the GIRRCS AOSD‐Study Group and the AIDA Network Still Disease Registry
Arthritis & Rheumatology 2024cited by 12position: middledoi
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study.
2024cited by 11position: contributordoi
P39 Analysis of nailfold capillaroscopy findings and clinical features of patients with systemic lupus erythematosus and pulmonary arterial hypertension
Poster presentations 2024cited by 1position: middledoi
Transient monoarthritis and psoriatic skin lesions following COVID-19.
2023cited by 47position: contributordoi
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients
Annals of the Rheumatic Diseases 2023cited by 36position: middledoi
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients.
2023cited by 31position: contributordoi
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry
RMD Open 2023cited by 24position: middledoi
Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission
Autoimmunity Reviews 2023cited by 18position: middledoi
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort
Joint Bone Spine 2023cited by 9position: middledoi
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort.
2023cited by 7position: contributordoi
Management of psoriatic arthritis: a consensus opinion by expert rheumatologists
Frontiers in Medicine 2023cited by 4position: middledoi
POS0852 REAL LIFE DATA OF FILGOTINIB IN RHEUMATOID ARTHRITIS PATIENTS: DATA FROM ITALIAN GISEA REGISTRY
Annals of the Rheumatic Diseases 2023cited by 1position: middledoi
AB0607 ANALYSIS OF NAILFOLD CAPILLAROSCOPY FINDINGS AND CLINICAL FEATURES OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND PULMONARY ARTERIAL HYPERTENSION
Annals of the Rheumatic Diseases 2023cited by 0position: middledoi
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
Nature Medicine 2022cited by 264position: middledoi
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies
Clinical and Experimental Rheumatology 2022cited by 39position: middledoi
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort
Lara D. Veeken 2022cited by 39position: middledoi
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still’s disease
Lara D. Veeken 2022cited by 38position: middledoi
The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET
Clinical and Experimental Rheumatology 2022cited by 30position: middledoi
Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still’s disease
Lara D. Veeken 2022cited by 29position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 19 papers (2020–2026)Marcello Govoni · University of Ferrara16 papers (2012–2023)Roberto Caporali · University of Milan14 papers (2013–2023)Carlo Alberto Scirè · University of Padua13 papers (2012–2022)Serena Bugatti · University Hospital Foundation12 papers (2021–2025)M. Manara · University of Ferrara11 papers (2012–2020)Luca Cantarini · Misericordia University10 papers (2019–2025) · 10 papers (2012–2019) · 10 papers (2012–2019) · 9 papers (2013–2022)Marco Matucci‐Cerinic · ENT and Allergy8 papers (2012–2019)Lorenzo Cavagna · Sanjay Gandhi Post Graduate Institute of Medical Sciences8 papers (2019–2022)Marco A. Cimmino · Università Campus Bio-Medico8 papers (2012–2019)Anǵela Tincani · Escola Superior de Saúde Ribeiro Sanches7 papers (2014–2022)Sara Monti · University of Turin7 papers (2019–2023) · 7 papers (2021–2025)Veronica Codullo · Foundation Center7 papers (2019–2026)Lorenzo Dagna · Hôpital Saint-Antoine6 papers (2019–2025) · 6 papers (2021–2023)Paolo Sfriso · University of Padua6 papers (2014–2025)